1149388-51-1 Usage
Description
Methyl 4-cyano-2-fluoro-5-nitrobenzoate is a chemical compound with the molecular formula C9H6FNO4. It is a yellow crystalline solid that is commonly used in organic synthesis and pharmaceutical research. As a derivative of benzoic acid, it contains a cyano group, a fluoro group, and a nitro group, making it useful for various chemical and biological applications. It is known for its potential as a building block in the production of pharmaceuticals and agrochemicals, as well as its role in the study of chemical reactions and mechanisms. However, it is important to handle this compound with caution, as it may pose health and environmental risks if not used properly.
Uses
Used in Pharmaceutical Industry:
Methyl 4-cyano-2-fluoro-5-nitrobenzoate is used as a building block for the production of pharmaceuticals. Its unique functional groups allow for the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
Methyl 4-cyano-2-fluoro-5-nitrobenzoate is also used as a building block for the production of agrochemicals. Its chemical structure can be utilized to create new pesticides or herbicides with improved efficacy and selectivity.
Used in Chemical Research:
Methyl 4-cyano-2-fluoro-5-nitrobenzoate is used in the study of chemical reactions and mechanisms. Its presence in various chemical processes can provide insights into reaction pathways and help develop new synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 1149388-51-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,9,3,8 and 8 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1149388-51:
(9*1)+(8*1)+(7*4)+(6*9)+(5*3)+(4*8)+(3*8)+(2*5)+(1*1)=181
181 % 10 = 1
So 1149388-51-1 is a valid CAS Registry Number.
1149388-51-1Relevant articles and documents
TROPANE COMPOUNDS
-
Page/Page column 447-448, (2009/05/30)
A compound according to Formula I or II: (I) or (II) wherein R1, R1b, R2, L1, and L2 and L2b are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
